newsfilter
← Latest News
PR Newswire·

Edgewise Therapeutics to Participate in Upcoming Investor Conferences

Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that management will participate in...